Jan 28, 2020

In accordance with a decision at the Annual General Meeting on May 29, 2019 in QuiaPEG Pharmaceuticals Holding AB, the three members of the Nomination Committee for the 2019 Annual General Meeting shall be appointed by the Company's two largest shareholders, according to voting rights, as of September 30, 2019, each entitled to nominate one member of the Nomination Committee. As the company's holders of the most shares declined to appoint a member to the nomination committee, Marcus Bosson, as the third largest shareholder, may therefore appoint a member. In addition, the Nomination Committee shall consist of one member appointed by the Board of Directors.

Download press release (PDF)
QuiaPEG Pharmaceuticals Holding AB

Virdings Allé 32 B
754 50 Uppsala
+46 (0) 70 693 12 53

User terms & privacy policy
Send a message